Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

The Utility and Practice of Electrodiagnostic Testing in the Pediatric Population: An AANEM Consensus Statement.

Kang PB, McMillan HJ, Kuntz NL, Lehky TJ, Alter KE, Fitzpatrick KF, El Kosseifi C, Quijano-Roy S; Professional Practice Committee of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Muscle Nerve. 2019 Nov 14. doi: 10.1002/mus.26752. [Epub ahead of print]

PMID:
31724199
2.

Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1.

Nelson CN, Dombi E, Rosenblum JS, Miettinen MM, Lehky TJ, Whitcomb PO, Hayes C, Scott G, Benzo S, Widemann BC, Chittiboina P.

J Neurosurg. 2019 Oct 25:1-11. doi: 10.3171/2019.7.JNS191353. [Epub ahead of print]

PMID:
31653805
3.

Utility of neuromuscular ultrasound for electromyographic needle localization within diseased muscle.

Ahmad OF, Saade D, Foley AR, Bönnemann C, Lehky T.

Muscle Nerve. 2019 Dec;60(6):E38-E40. doi: 10.1002/mus.26698. Epub 2019 Sep 30. No abstract available.

PMID:
31498902
4.

Clinical Evaluation of Melorheostosis in the Context of a Natural History Clinical Study.

Jha S, Cowen EW, Lehky TJ, Alter K, Flynn L, Reynolds JC, Lange E, Katz JD, Marini JC, Siegel RM, Bhattacharyya T.

JBMR Plus. 2019 Jul 26;3(8):e10214. doi: 10.1002/jbm4.10214. eCollection 2019 Aug.

5.

Haploinsufficiency of the brain-derived neurotrophic factor gene is associated with reduced pain sensitivity.

Sapio MR, Iadarola MJ, LaPaglia DM, Lehky T, Thurm AE, Danley KM, Fuhr SR, Lee MD, Huey AE, Sharp SJ, Tsao JW, Yanovski JA, Mannes AJ, Han JC.

Pain. 2019 May;160(5):1070-1081. doi: 10.1097/j.pain.0000000000001485.

6.

Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.

Mammen AL, Rajan A, Pak K, Lehky T, Casciola-Rosen L, Donahue RN, Lepone LM, Zekeridou A, Pittock SJ, Hassan R, Schlom J, Gulley JL.

Ann Rheum Dis. 2019 Jan;78(1):150-152. doi: 10.1136/annrheumdis-2018-213777. Epub 2018 Sep 5. No abstract available.

PMID:
30185415
7.

Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

Jha S, Fratzl-Zelman N, Roschger P, Papadakis GZ, Cowen EW, Kang H, Lehky TJ, Alter K, Deng Z, Ivovic A, Flynn L, Reynolds JC, Dasgupta A, Miettinen M, Lange E, Katz J, Klaushofer K, Marini JC, Siegel RM, Bhattacharyya T.

J Bone Miner Res. 2019 Jan;34(1):145-156. doi: 10.1002/jbmr.3577. Epub 2018 Sep 14.

PMID:
30138550
8.

Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters.

Grunseich C, Wang IX, Watts JA, Burdick JT, Guber RD, Zhu Z, Bruzel A, Lanman T, Chen K, Schindler AB, Edwards N, Ray-Chaudhury A, Yao J, Lehky T, Piszczek G, Crain B, Fischbeck KH, Cheung VG.

Mol Cell. 2018 Feb 1;69(3):426-437.e7. doi: 10.1016/j.molcel.2017.12.030. Epub 2018 Jan 27.

9.

Electrical impedance myography in individuals with collagen 6 and laminin α-2 congenital muscular dystrophy: a cross-sectional and 2-year analysis.

Nichols C, Jain MS, Meilleur KG, Wu T, Collins J, Waite MR, Dastgir J, Salman A, Donkervoort S, Duong T, Keller K, Leach ME, Lott DJ, McGuire MN, Nelson L, Rutkowski A, Vuillerot C, Bönnemann CG, Lehky TJ.

Muscle Nerve. 2018 Jan;57(1):54-60. doi: 10.1002/mus.25629. Epub 2017 Apr 25.

10.

Neurologic involvement in patients with atypical Chediak-Higashi disease.

Introne WJ, Westbroek W, Groden CA, Bhambhani V, Golas GA, Baker EH, Lehky TJ, Snow J, Ziegler SG, Malicdan MC, Adams DR, Dorward HM, Hess RA, Huizing M, Gahl WA, Toro C.

Neurology. 2017 Feb 14;88(7):e57-e65. doi: 10.1212/WNL.0000000000003622.

11.

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment.

Kosa P, Ghazali D, Tanigawa M, Barbour C, Cortese I, Kelley W, Snyder B, Ohayon J, Fenton K, Lehky T, Wu T, Greenwood M, Nair G, Bielekova B.

Front Neurol. 2016 Aug 15;7:131. doi: 10.3389/fneur.2016.00131. eCollection 2016.

12.

Peripheral nervous system manifestations of Chediak-Higashi disease.

Lehky TJ, Groden C, Lear B, Toro C, Introne WJ.

Muscle Nerve. 2017 Mar;55(3):359-365. doi: 10.1002/mus.25259. Epub 2016 Dec 16.

13.

Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation.

Lam C, Ferreira C, Krasnewich D, Toro C, Latham L, Zein WM, Lehky T, Brewer C, Baker EH, Thurm A, Farmer CA, Rosenzweig SD, Lyons JJ, Schreiber JM, Gropman A, Lingala S, Ghany MG, Solomon B, Macnamara E, Davids M, Stratakis CA, Kimonis V, Gahl WA, Wolfe L.

Genet Med. 2017 Feb;19(2):160-168. doi: 10.1038/gim.2016.75. Epub 2016 Jul 7.

PMID:
27388694
14.

Neurologic involvement in patients with atypical Chediak-Higashi disease.

Introne WJ, Westbroek W, Cullinane AR, Groden CA, Bhambhani V, Golas GA, Baker EH, Lehky TJ, Snow J, Ziegler SG, Adams DR, Dorward HM, Hess RA, Huizing M, Gahl WA, Toro C.

Neurology. 2016 Apr 5;86(14):1320-1328. doi: 10.1212/WNL.0000000000002551. Epub 2016 Mar 4. Erratum in: Neurology. 2017 Feb 14;88(7):720. Neurology. 2017 Feb 14;88(7):721. Corrected and republished in: Neurology. 2017 Feb 14;88(7):e57-e65.

15.

Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.

Schanz O, Bageac D, Braun L, Traynor BJ, Lehky TJ, Floeter MK.

Muscle Nerve. 2016 Aug;54(2):264-9. doi: 10.1002/mus.25047. Epub 2016 May 25.

16.

Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy.

Mankodi A, Grunseich C, Skov M, Cook L, Aue G, Purev E, Bakar D, Lehky T, Jurkat-Rott K, Pedersen TH, Childs RW.

Neuromuscul Disord. 2015 Nov;25(11):908-12. doi: 10.1016/j.nmd.2015.08.007. Epub 2015 Aug 20.

17.

Electrical impedance myography discriminates congenital muscular dystrophy from controls.

Schwartz DP, Dastgir J, Salman A, Lear B, Bönnemann CG, Lehky TJ.

Muscle Nerve. 2016 Mar;53(3):402-6. doi: 10.1002/mus.24770. Epub 2015 Aug 13.

PMID:
26179210
18.

Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency.

Grunseich C, Schindler AB, Chen KL, Bakar D, Mankodi A, Traslavina R, Ray-Chaudhury A, Lehky TJ, Baker EH, Maragakis NJ, Tifft CJ, Fischbeck KH.

J Neurol. 2015;262(4):1066-8. doi: 10.1007/s00415-015-7683-x. Epub 2015 Mar 4. No abstract available.

19.

Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.

Grunseich C, Kats IR, Bott LC, Rinaldi C, Kokkinis A, Fox D, Chen KL, Schindler AB, Mankodi AK, Shrader JA, Schwartz DP, Lehky TJ, Liu CY, Fischbeck KH.

Neuromuscul Disord. 2014 Nov;24(11):978-81. doi: 10.1016/j.nmd.2014.06.441. Epub 2014 Jul 3.

20.

Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).

Pierson TM, Markello T, Accardi J, Wolfe L, Adams D, Sincan M, Tarazi NM, Fajardo KF, Cherukuri PF, Bajraktari I, Meilleur KG, Donkervoort S, Jain M, Hu Y, Lehky TJ, Cruz P, Mullikin JC, Bonnemann C, Gahl WA, Boerkoel CF, Tifft CJ.

Neuromuscul Disord. 2013 Jun;23(6):483-8. doi: 10.1016/j.nmd.2013.01.013. Epub 2013 Mar 1.

21.

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Wang XM, Lehky TJ, Brell JM, Dorsey SG.

Cytokine. 2012 Jul;59(1):3-9. doi: 10.1016/j.cyto.2012.03.027. Epub 2012 Apr 24. Review.

22.

Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.

Lehky TJ, Iwamoto FM, Kreisl TN, Floeter MK, Fine HA.

Neurology. 2011 Jan 18;76(3):236-41. doi: 10.1212/WNL.0b013e3182074a69.

23.

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

Fernández-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen C, Di Prospero NA, Fischbeck KH.

Lancet Neurol. 2011 Feb;10(2):140-7. doi: 10.1016/S1474-4422(10)70321-5. Epub 2011 Jan 6.

24.

Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings.

Cable C, Finkel RS, Lehky TJ, Biassou NM, Wiggs EA, Bunin N, Pierson TM.

Mol Genet Metab. 2011 Feb;102(2):207-9. doi: 10.1016/j.ymgme.2010.10.002. Epub 2010 Oct 28.

25.

Clinical features of spinal and bulbar muscular atrophy.

Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, Lehky TJ, Shrader JA, Levy EW, Harris-Love M, Di Prospero NA, Fischbeck KH.

Brain. 2009 Dec;132(Pt 12):3242-51. doi: 10.1093/brain/awp258.

26.

Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy.

Lehky TJ, Chen CJ, di Prospero NA, Rhodes LE, Fischbeck K, Floeter MK.

Muscle Nerve. 2009 Nov;40(5):809-14. doi: 10.1002/mus.21399.

27.

Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Kato GJ, Hsieh M, Machado R, Taylor J 6th, Little J, Butman JA, Lehky T, Tisdale J, Gladwin MT.

Am J Hematol. 2006 Jul;81(7):503-10.

28.

Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.

Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK.

Muscle Nerve. 2004 Mar;29(3):387-92.

PMID:
14981738
29.

Acute oxaliplatin-induced peripheral nerve hyperexcitability.

Wilson RH, Lehky T, Thomas RR, Quinn MG, Floeter MK, Grem JL.

J Clin Oncol. 2002 Apr 1;20(7):1767-74.

PMID:
11919233
30.

HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.

Soldan SS, Graf MD, Waziri A, Flerlage AN, Robinson SM, Kawanishi T, Leist TP, Lehky TJ, Levin MC, Jacobson S.

J Infect Dis. 1999 Sep;180(3):685-94.

PMID:
10438355
31.

Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.

Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, Fleisher TA, Top LE, Light S, McFarland HF, Waldmann TA, Jacobson S.

Ann Neurol. 1998 Dec;44(6):942-7.

PMID:
9851439
32.

Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.

Levin MC, Lehky TJ, Flerlage AN, Katz D, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S.

N Engl J Med. 1997 Mar 20;336(12):839-45. No abstract available.

34.

Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease.

Levin MC, Krichavsky M, Fox RJ, Lehky T, Jacobson S, Fox C, Kleghorn F, White J, Young N, Edwards RJ, Jack NE, Bartholomew C.

Blood. 1997 Jan 1;89(1):346-8. No abstract available.

PMID:
8978312
35.

Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles.

Lehky TJ, Flerlage N, Katz D, Houff S, Hall WH, Ishii K, Monken C, Dhib-Jalbut S, McFarland HF, Jacobson S.

Ann Neurol. 1996 Nov;40(5):714-23.

PMID:
8957012
37.

Induction of HLA class II in HTLV-I infected neuronal cell lines.

Lehky TJ, Jacobson S.

J Neurovirol. 1995 Jun;1(2):145-56.

PMID:
9222353
38.

Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization.

Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S.

Ann Neurol. 1995 Feb;37(2):167-75.

PMID:
7847858
39.

In situ PCR for the detection of HTLV-I in HAM/TSP patients.

Walter MJ, Lehky TJ, Fox CH, Jacobson S.

Ann N Y Acad Sci. 1994 Jun 6;724:404-13. Review. No abstract available.

PMID:
8030966
40.
41.
42.
43.

Myelin basic protein-specific T cell lines and clones derived from SJL/J mice with experimental allergic encephalomyelitis.

Richert JR, Lehky TJ, Muehl LA, Mingioli ES, McFarlin DE.

J Neuroimmunol. 1985 May;8(2-3):129-39.

PMID:
2581993
44.

[On the action of a modified bovine serum in animal experiments. (Preliminary report)].

Knesslová V, Lehký T.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1966;86(2):226-34. German. No abstract available.

PMID:
4167558
45.
46.

[METABOLISM OF HETEROPLASMA.IV. FORMATION OF UREA AND AMMONIA].

NIKL J, LEHKY T, STERBIKOVA J, JEHLICKOVA M.

Cesk Gastroenterol Vyz. 1963 Nov;17:411-21. Czech. No abstract available.

PMID:
14187022
47.

[STUDY OF THE EFFECT OF DEXTRAN ON THE PATHOGENESIS OF ALLERGIC REACTIONS IN RATS].

LEHKY T, ZMESKALOVA D, MALEK J.

Cesk Farm. 1963 Jun;12:251-3. Czech. No abstract available.

PMID:
14076176
48.

[Use of heterologous plasma with glutathione in exsanguinated experimental animals].

HOREJSI J, LEHKY T, NIKL J, ZMESKALOVA D.

Rozhl Chir. 1962 Oct;41:662-6. Czech. No abstract available.

PMID:
13961747
49.
50.

[Study of the antithrombotic effect of plasmin with the aid of a new method].

HLADOVEC J, LEHKY T, RYBAK M.

Z Gesamte Inn Med. 1960 Dec 1;15:1125-6. German. No abstract available.

PMID:
13714722

Supplemental Content

Support Center